Stocks Pivot Higher, Look to Extend Rebound

Fed Chair Jerome Powell reinforced his support for tighter economic policy

Digital Content Manager
Sep 8, 2022 at 11:55 AM
facebook twitter linkedin


The Dow Jones Industrial Average (DJI) is up 179 points this afternoon, at least for now brushing off concerns about a hawkish Fed. Both the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) boast solid gains of their own, with healthcare and bank stocks leading the way. Upbeat jobless data is helping overshadow the latest comments from Federal Reserve Chairman Jerome Powell, who reiterated his commitment to fighting inflation with aggressive interest rate hikes. 

Continue reading for more on today's market, including:

  • Climate bill tailwinds could make solar stock shine.
  • Options bulls rushing Moderna stock after upgrade.
  • Plus, LYFT's latest bearish coverage; pharmaceutical stock surges on ALS drug approval; and unpacking BILI's post-earnings tumble.

MMC Stats 0908

Ridesharing name Lyft Inc (NASDAQ: LYFT) is seeing heightened options volume in its options pits today. So far, 89,000 calls and 22,000 puts have been traded, volume that's eight times the average intraday amount. The 9/9 14.50-strike call is by far the most popular contract, followed by the 15-strike call in the same weekly series, with new positions being opened at both. Up 10.3% at $16.20 at last check, LYFT is brushing off new coverage from BofA Global Research, which initiated an "underperform" rating and $14 price target. Shares are bouncing off a recent pullback to the $14 level, and are today looking to overcome short-term resistance at the $16 region.

Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) is one of the top performers on the Nasdaq today, last seen up 59.9% at $28.63, after a Federal Drug Administration (FDA) panel of neurologists voted in favor of the company's amyotrophic lateral sclerosis (ALS) drug. In response, SVB Securities and Citigroup hiked their price targets on AMLX to $50 and $48, respectively. Shares are today trading at their highest level since February, and have added a whopping 116.8% over the last three months.

Meanwhile, Bilibili Inc (NASDAQ:BILI) is towards the bottom of the Nasdaq, down 14.2% to trade at $20.27 at last glance, after the Chinese tech company announced wider-than-expected second-quarter losses and a revenue miss. BILI earlier fell to its lowest level since late May, breaching the $22 level, a floor that contained multiple pullbacks over the last three months. Year-to-date, BILI is down 55.9%.

BILI Intraday

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners